Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Jules Leonard Dienstag, M.D.

TitleDean for Medical Education
InstitutionHarvard Medical School
DepartmentPME
AddressHarvard Medical School
Office of the Dean for Medical Education, Gordon Hall
25 Shattuck St
Boston MA 02115
Phone617/432-6250
Fax617/432-6253
Other Positions
TitleCarl W. Walter Professor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
DivisionGastrointestinal Unit


 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Leape L, Shore M, Dienstag JL. In reply to alexander et Al. Acad Med. 2013 Jun; 88(6):741-4.
    View in: PubMed
  2. Dienstag JL, Cosimi AB. Liver transplantation--a vision realized. N Engl J Med. 2012 Oct 18; 367(16):1483-5.
    View in: PubMed
  3. Dienstag JL. The case for the new MCAT. N Engl J Med. 2012 Jul 19; 367(3):280-1; author reply 281-2.
    View in: PubMed
  4. Leape LL, Shore MF, Dienstag JL, Mayer RJ, Edgman-Levitan S, Meyer GS, Healy GB. Perspective: a culture of respect, part 1: the nature and causes of disrespectful behavior by physicians. Acad Med. 2012 Jul; 87(7):845-52.
    View in: PubMed
  5. Leape LL, Shore MF, Dienstag JL, Mayer RJ, Edgman-Levitan S, Meyer GS, Healy GB. Perspective: a culture of respect, part 2: creating a culture of respect. Acad Med. 2012 Jul; 87(7):853-8.
    View in: PubMed
  6. Corey KE, Zheng H, Mendez-Navarro J, Delgado-Borrego A, Dienstag JL, Chung RT. Serum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis. PLoS One. 2012; 7(2):e27144.
    View in: PubMed
  7. Dienstag JL. The Medical College Admission Test--toward a new balance. N Engl J Med. 2011 Nov 24; 365(21):1955-7.
    View in: PubMed
  8. Fontana RJ, Litman HJ, Dienstag JL, Bonkovsky HL, Su G, Sterling RK, Lok AS. YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C. Liver Int. 2012 Apr; 32(4):665-74.
    View in: PubMed
  9. Sterling RK, Wright EC, Morgan TR, Seeff LB, Hoefs JC, Di Bisceglie AM, Dienstag JL, Lok AS. Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C. Am J Gastroenterol. 2012 Jan; 107(1):64-74.
    View in: PubMed
  10. Dienstag JL, Ghany MG, Morgan TR, Di Bisceglie AM, Bonkovsky HL, Kim HY, Seeff LB, Szabo G, Wright EC, Sterling RK, Everson GT, Lindsay KL, Lee WM, Lok AS, Morishima C, Stoddard AM, Everhart JE. A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. Hepatology. 2011 Aug; 54(2):396-405.
    View in: PubMed
  11. Hoefs JC, Shiffman ML, Goodman ZD, Kleiner DE, Dienstag JL, Stoddard AM. Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. Gastroenterology. 2011 Sep; 141(3):900-908.e1-2.
    View in: PubMed
  12. Di Bisceglie AM, Stoddard AM, Dienstag JL, Shiffman ML, Seeff LB, Bonkovsky HL, Morishima C, Wright EC, Snow KK, Lee WM, Fontana RJ, Morgan TR, Ghany MG. Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon. Hepatology. 2011 Apr; 53(4):1100-8.
    View in: PubMed
  13. Abu Dayyeh BK, Yang M, Fuchs BC, Karl DL, Yamada S, Sninsky JJ, O'Brien TR, Dienstag JL, Tanabe KK, Chung RT. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma. Gastroenterology. 2011 Jul; 141(1):141-9.
    View in: PubMed
  14. Dienstag JL. Evolution of the New Pathway curriculum at Harvard Medical School: the new integrated curriculum. Perspect Biol Med. 2011; 54(1):36-54.
    View in: PubMed
  15. Abu Dayyeh BK, Yang M, Dienstag JL, Chung RT. The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort. Dig Dis Sci. 2011 Feb; 56(2):564-8.
    View in: PubMed
  16. Lok AS, Everhart JE, Wright EC, Di Bisceglie AM, Kim HY, Sterling RK, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Morgan TR. Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C. Gastroenterology. 2011 Mar; 140(3):840-9; quiz e12.
    View in: PubMed
  17. Morgan TR, Ghany MG, Kim HY, Snow KK, Shiffman ML, De Santo JL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Dienstag JL, Morishima C, Lindsay KL, Lok AS. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology. 2010 Sep; 52(3):833-44.
    View in: PubMed
  18. Dienstag JL, Neill JM. Harvard Medical School. Acad Med. 2010 Sep; 85(9 Suppl):S269-73.
    View in: PubMed
  19. Dienstag JL. Peginterferon therapy for HBeAg-negative chronic hepatitis B: less than meets the eye. Am J Gastroenterol. 2010 Aug; 105(8):1770-2.
    View in: PubMed
  20. Fontana RJ, Dienstag JL, Bonkovsky HL, Sterling RK, Naishadham D, Goodman ZD, Lok AS, Wright EC, Su GL. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut. 2010 Oct; 59(10):1401-9.
    View in: PubMed
  21. Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, Shiffman ML, Fontana RJ, Di Bisceglie AM, Bonkovsky HL, Dienstag JL. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol. 2010 Oct; 8(10):877-83.
    View in: PubMed
  22. Peters MG, Weinbaum C, Tan L, Baine WB, Dienstag JL, Liang TJ, So S. Recommendations for prevention, screening, and diagnosis of HBV and HCV infections. J Fam Pract. 2010 Apr; 59(4 Suppl):S29-35.
    View in: PubMed
  23. Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE, Ghany MG, Mills AS, Nash SR, Govindarajan S, Rogers TE, Greenson JK, Brunt EM, Bonkovsky HL, Morishima C, Litman HJ. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology. 2010 Feb; 51(2):585-94.
    View in: PubMed
  24. Snow KK, Bonkovsky HL, Fontana RJ, Kim HY, Sterling RK, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG. Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2010 Apr; 31(7):719-34.
    View in: PubMed
  25. Goodman ZD, Stoddard AM, Bonkovsky HL, Fontana RJ, Ghany MG, Morgan TR, Wright EC, Brunt EM, Kleiner DE, Shiffman ML, Everson GT, Lindsay KL, Dienstag JL, Morishima C. Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial. Hepatology. 2009 Dec; 50(6):1738-49.
    View in: PubMed
  26. Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology. 2009 Nov; 50(5):1360-9.
    View in: PubMed
  27. Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, Dienstag JL. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology. 2010 Feb; 138(2):493-502.
    View in: PubMed
  28. Bardes CL, Best PC, Kremer SJ, Dienstag JL. Perspective: Medical school admissions and noncognitive testing: some open questions. Acad Med. 2009 Oct; 84(10):1360-3.
    View in: PubMed
  29. Corey KE, Servoss JC, Casson DR, Kim AY, Robbins GK, Franzini J, Twitchell K, Loomis SC, Abraczinskas DR, Terella AM, Dienstag JL, Chung RT. Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers. Infect Control Hosp Epidemiol. 2009 Oct; 30(10):1000-5.
    View in: PubMed
  30. Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology. 2010 Jan; 138(1):136-46.
    View in: PubMed
  31. Shiffman ML, Morishima C, Dienstag JL, Lindsay KL, Hoefs JC, Lee WM, Wright EC, Naishadham D, Everson GT, Lok AS, Di Bisceglie AM, Bonkovsky HL, Ghany MG. Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial. Gastroenterology. 2009 Dec; 137(6):1986-94.
    View in: PubMed
  32. Krupat E, Dienstag JL. Commentary: Assessment is an educational tool. Acad Med. 2009 May; 84(5):548-50.
    View in: PubMed
  33. Dienstag JL. Benefits and risks of nucleoside analog therapy for hepatitis B. Hepatology. 2009 May; 49(5 Suppl):S112-21.
    View in: PubMed
  34. Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med. 2008 Dec 4; 359(23):2429-41.
    View in: PubMed
  35. Fontana RJ, Bonkovsky HL, Naishadham D, Dienstag JL, Sterling RK, Lok AS, Su GL. Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):219-26.
    View in: PubMed
  36. Morishima C, Morgan TR, Everhart JE, Wright EC, Apodaca MC, Gretch DR, Shiffman ML, Everson GT, Lindsay KL, Lee WM, Lok AS, Dienstag JL, Ghany MG, Curto TM. Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C. Hepatology. 2008 Nov; 48(5):1412-9.
    View in: PubMed
  37. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008 Oct 2; 359(14):1486-500.
    View in: PubMed
  38. Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009 Jan; 136(1):138-48.
    View in: PubMed
  39. Dienstag JL. Relevance and rigor in premedical education. N Engl J Med. 2008 Jul 17; 359(3):221-4.
    View in: PubMed
  40. Dienstag JL. Hepatitis A: the vaccine dividend. J Infect Dis. 2008 May 1; 197(9):1220-2.
    View in: PubMed
  41. Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, Sterling RK, Su GL, Ghosh M, Wright EC. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology. 2008 Mar; 47(3):789-98.
    View in: PubMed
  42. Lindsay KL, Morishima C, Wright EC, Dienstag JL, Shiffman ML, Everson GT, Lok AS, Bonkovsky HL, Lee WM, Morgan TR, Ghany MG. Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C. Clin Gastroenterol Hepatol. 2008 Feb; 6(2):234-41.
    View in: PubMed
  43. Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG. Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. Hepatology. 2008 Feb; 47(2):605-12.
    View in: PubMed
  44. Reddy KR, Govindarajan S, Marcellin P, Bernstein D, Dienstag JL, Bodenheimer H, Rakela J, Messinger D, Schmidt G, Ackrill A, Hadziyannis SJ. Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin. J Viral Hepat. 2008 Feb; 15(2):129-36.
    View in: PubMed
  45. Min AD, Dienstag JL. Oral antivirals for chronic hepatitis B. Clin Liver Dis. 2007 Nov; 11(4):851-68, ix.
    View in: PubMed
  46. Dienstag J, Easley C, Kirkpatrick P. Telbivudine. Nat Rev Drug Discov. 2007 Apr; 6(4):267-8.
    View in: PubMed
  47. Dienstag JL, Wei LJ, Xu D, Kreter B. Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients. Clin Drug Investig. 2007; 27(1):35-49.
    View in: PubMed
  48. Bourne EJ, Dienstag JL, Lopez VA, Sander TJ, Longlet JM, Hall JG, Kwiatkowski RW, Wright T, Lai CL, Condreay LD. Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy. J Viral Hepat. 2007 Jan; 14(1):55-63.
    View in: PubMed
  49. Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, Kahn JA, Lok AS, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Morishima C. Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial. Hepatology. 2006 Dec; 44(6):1675-84.
    View in: PubMed
  50. Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol. 2007 Mar; 46(3):420-31.
    View in: PubMed
  51. Shiffman ML, Ghany MG, Morgan TR, Wright EC, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Gretch DR. Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C. Gastroenterology. 2007 Jan; 132(1):103-12.
    View in: PubMed
  52. Morishima C, Morgan TR, Everhart JE, Wright EC, Shiffman ML, Everson GT, Lindsay KL, Lok AS, Bonkovsky HL, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Gretch DR. HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial. Hepatology. 2006 Aug; 44(2):360-7.
    View in: PubMed
  53. Dienstag JL. Hepatitis C: a bitter harvest. Ann Intern Med. 2006 May 16; 144(10):770-1.
    View in: PubMed
  54. Dienstag JL. Looking to the future: new agents for chronic hepatitis B. Am J Gastroenterol. 2006; 101 Suppl 1:S19-25.
    View in: PubMed
  55. Dienstag JL, McHutchison JG. American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology. 2006 Jan; 130(1):231-64; quiz 214-7.
    View in: PubMed
  56. Dienstag JL, McHutchison JG. American Gastroenterological Association medical position statement on the management of hepatitis C. Gastroenterology. 2006 Jan; 130(1):225-30.
    View in: PubMed
  57. Wright TL, Avunduk C, Dienstag JL, Freston JW, Jacobson IM, Nord HJ, Sherman M. Advancing patient care: integrating new data. Am J Gastroenterol. 2006; 101 Suppl 1:S32-9.
    View in: PubMed
  58. Di Bisceglie AM, Sterling RK, Chung RT, Everhart JE, Dienstag JL, Bonkovsky HL, Wright EC, Everson GT, Lindsay KL, Lok AS, Lee WM, Morgan TR, Ghany MG, Gretch DR. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. J Hepatol. 2005 Sep; 43(3):434-41.
    View in: PubMed
  59. Di Giammarino L, Dienstag JL. Hepatitis A--the price of progress. N Engl J Med. 2005 Sep 1; 353(9):944-6.
    View in: PubMed
  60. Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM, Lee WM, Morgan TR, Dienstag JL, Morishima C. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology. 2005 Aug; 42(2):282-92.
    View in: PubMed
  61. Dienstag JL. The value and limitations of long-term nucleoside antiviral therapy in chronic hepatitis B. J Hepatol. 2005 Feb; 42(2):158-62.
    View in: PubMed
  62. Lee WM, Dienstag JL, Lindsay KL, Lok AS, Bonkovsky HL, Shiffman ML, Everson GT, Di Bisceglie AM, Morgan TR, Ghany MG, Morishima C, Wright EC, Everhart JE. Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Control Clin Trials. 2004 Oct; 25(5):472-92.
    View in: PubMed
  63. Shiffman ML, Di Bisceglie AM, Lindsay KL, Morishima C, Wright EC, Everson GT, Lok AS, Morgan TR, Bonkovsky HL, Lee WM, Dienstag JL, Ghany MG, Goodman ZD, Everhart JE. Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment. Gastroenterology. 2004 Apr; 126(4):1015-23; discussion 947.
    View in: PubMed
  64. Kuo A, Dienstag JL, Chung RT. Tenofovir disoproxil fumarate for the treatment of lamivudine-resistant hepatitis B. Clin Gastroenterol Hepatol. 2004 Mar; 2(3):266-72.
    View in: PubMed
  65. Lok AS, Lai CL, Leung N, Yao GB, Cui ZY, Schiff ER, Dienstag JL, Heathcote EJ, Little NR, Griffiths DA, Gardner SD, Castiglia M. Long-term safety of lamivudine treatment in patients with chronic hepatitis B. Gastroenterology. 2003 Dec; 125(6):1714-22.
    View in: PubMed
  66. Schiff ER, Dienstag JL, Karayalcin S, Grimm IS, Perrillo RP, Husa P, de Man RA, Goodman Z, Condreay LD, Crowther LM, Woessner MA, McPhillips PJ, Brown NA. Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders. J Hepatol. 2003 Jun; 38(6):818-26.
    View in: PubMed
  67. Dienstag JL, Cianciara J, Karayalcin S, Kowdley KV, Willems B, Plisek S, Woessner M, Gardner S, Schiff E. Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology. 2003 Apr; 37(4):748-55.
    View in: PubMed
  68. Lai CL, Dienstag J, Schiff E, Leung NW, Atkins M, Hunt C, Brown N, Woessner M, Boehme R, Condreay L. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis. 2003 Mar 15; 36(6):687-96.
    View in: PubMed
  69. Dienstag JL, Goldin RD, Heathcote EJ, Hann HW, Woessner M, Stephenson SL, Gardner S, Gray DF, Schiff ER. Histological outcome during long-term lamivudine therapy. Gastroenterology. 2003 Jan; 124(1):105-17.
    View in: PubMed
  70. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology. 2002 Nov; 36(5 Suppl 1):S152-60.
    View in: PubMed
  71. McHutchison JG, Manns M, Patel K, Poynard T, Lindsay KL, Trepo C, Dienstag J, Lee WM, Mak C, Garaud JJ, Albrecht JK. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology. 2002 Oct; 123(4):1061-9.
    View in: PubMed
  72. Perrillo RP, Lai CL, Liaw YF, Dienstag JL, Schiff ER, Schalm SW, Heathcote EJ, Brown NA, Atkins M, Woessner M, Gardner SD. Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology. 2002 Jul; 36(1):186-94.
    View in: PubMed
  73. McHutchison JG, Poynard T, Esteban-Mur R, Davis GL, Goodman ZD, Harvey J, Ling MH, Garaud JJ, Albrecht JK, Patel K, Dienstag JL, Morgan T. Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin. Hepatology. 2002 Mar; 35(3):688-93.
    View in: PubMed
  74. Rosenberg PM, Farrell JJ, Abraczinskas DR, Graeme-Cook FM, Dienstag JL, Chung RT. Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection. Am J Gastroenterol. 2002 Feb; 97(2):478-83.
    View in: PubMed
  75. Kweon YO, Goodman ZD, Dienstag JL, Schiff ER, Brown NA, Burchardt E, Schoonhoven R, Brenner DA, Fried MW, Burkhardt E. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol. 2001 Dec; 35(6):749-55.
    View in: PubMed
  76. McHutchison JG, Shad JA, Gordon SC, Morgan TR, Ling MH, Garaud JJ, Albrecht JK, Dienstag JL. Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy. J Viral Hepat. 2001 Nov; 8(6):414-20.
    View in: PubMed
  77. Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Schinazi RF. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology. 2001 Mar; 33(3):751-7.
    View in: PubMed
  78. Perrillo RP, Wright T, Rakela J, Levy G, Schiff E, Gish R, Martin P, Dienstag J, Adams P, Dickson R, Anschuetz G, Bell S, Condreay L, Brown N. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology. 2001 Feb; 33(2):424-32.
    View in: PubMed
  79. McHutchison JG, Poynard T, Pianko S, Gordon SC, Reid AE, Dienstag J, Morgan T, Yao R, Albrecht J. The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group. Gastroenterology. 2000 Nov; 119(5):1317-23.
    View in: PubMed
  80. Dienstag JL. Alternative therapy si, gene therapy no? Gastroenterology. 2000 Nov; 119(5):1189.
    View in: PubMed
  81. Purcell RH, Alter HJ, Dienstag JL. Non-A, non-B hepatitis. 1976. Yale J Biol Med. 2000 Jan-Dec; 73(1-6):175-82.
    View in: PubMed
  82. Gauthier J, Bourne EJ, Lutz MW, Crowther LM, Dienstag JL, Brown NA, Condreay LD. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Infect Dis. 1999 Dec; 180(6):1757-62.
    View in: PubMed
  83. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med. 1999 Oct 21; 341(17):1256-63.
    View in: PubMed
  84. Dienstag JL, Schiff ER, Mitchell M, Casey DE, Gitlin N, Lissoos T, Gelb LD, Condreay L, Crowther L, Rubin M, Brown N. Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapy. Hepatology. 1999 Oct; 30(4):1082-7.
    View in: PubMed
  85. Dienstag JL. New antiviral agents for viral hepatitis: our cup runneth over but is only half full. Gastroenterology. 1999 Sep; 117(3):525.
    View in: PubMed
  86. Chung RT, Monto A, Dienstag JL, Kaplan LM. Mutations in the NS5A region do not predict interferon-responsiveness in american patients infected with genotype 1b hepatitis C virus. J Med Virol. 1999 Aug; 58(4):353-8.
    View in: PubMed
  87. Reid AE, Koziel MJ, Aiza I, Jeffers L, Reddy R, Schiff E, Lau JY, Dienstag JL, Liang TJ. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States. Am J Gastroenterol. 1999 Jun; 94(6):1619-26.
    View in: PubMed
  88. Perrillo R, Rakela J, Dienstag J, Levy G, Martin P, Wright T, Caldwell S, Schiff E, Gish R, Villeneuve JP, Farr G, Anschuetz G, Crowther L, Brown N. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology. 1999 May; 29(5):1581-6.
    View in: PubMed
  89. Toth CM, Pascual M, Chung RT, Graeme-Cook F, Dienstag JL, Bhan AK, Cosimi AB. Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation. 1998 Nov 15; 66(9):1254-8.
    View in: PubMed
  90. Wong DK, Dudley DD, Afdhal NH, Dienstag J, Rice CM, Wang L, Houghton M, Walker BD, Koziel MJ. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol. 1998 Feb 1; 160(3):1479-88.
    View in: PubMed
  91. Dienstag JL. Sexual and perinatal transmission of hepatitis C. Hepatology. 1997 Sep; 26(3 Suppl 1):66S-70S.
    View in: PubMed
  92. Dienstag JL. Management of chronic hepatitis C: a consensus. Gastroenterology. 1997 Aug; 113(2):375.
    View in: PubMed
  93. Dienstag JL. The natural history of chronic hepatitis C and what we should do about it. Gastroenterology. 1997 Feb; 112(2):651-5.
    View in: PubMed
  94. Lindsay KL, Davis GL, Schiff ER, Bodenheimer HC, Balart LA, Dienstag JL, Perrillo RP, Tamburro CH, Goff JS, Everson GT, Silva M, Katkov WN, Goodman Z, Lau JY, Maertens G, Gogate J, Sanghvi B, Albrecht J. Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group. Hepatology. 1996 Nov; 24(5):1034-40.
    View in: PubMed
  95. Harper SE, Dienstag JL. Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis? Hepatology. 1996 Apr; 23(4):930-3.
    View in: PubMed
  96. Dershwitz M, Hoke JF, Rosow CE, Michalowski P, Connors PM, Muir KT, Dienstag JL. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology. 1996 Apr; 84(4):812-20.
    View in: PubMed
  97. Johnson MW, Washburn WK, Freeman RB, FitzMaurice SE, Dienstag J, Basgoz N, Jenkins RL, Cosimi AB. Hepatitis C viral infection in liver transplantation. Arch Surg. 1996 Mar; 131(3):284-91.
    View in: PubMed
  98. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med. 1995 Dec 21; 333(25):1657-61.
    View in: PubMed
  99. Dec GW, Kondo N, Farrell ML, Dienstag J, Cosimi AB, Semigran MJ. Cardiovascular complications following liver transplantation. Clin Transplant. 1995 Dec; 9(6):463-71.
    View in: PubMed
  100. Katkov WN, Dienstag JL. Hepatitis vaccines. Gastroenterol Clin North Am. 1995 Mar; 24(1):147-59.
    View in: PubMed
  101. Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis. 1995 Feb; 15(1):101-9.
    View in: PubMed
  102. Rall CJ, Dienstag JL. Epidemiology of hepatitis C virus infection. Semin Gastrointest Dis. 1995 Jan; 6(1):3-12.
    View in: PubMed
  103. Eason JD, Freeman RB, Rohrer RJ, Lewis WD, Jenkins R, Dienstag J, Cosimi AB. Should liver transplantation be performed for patients with hepatitis B? Transplantation. 1994 Jun 15; 57(11):1588-93.
    View in: PubMed
  104. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, et al. Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther. 1994 Mar-Apr; 16(2):334-43; discussion 271-2.
    View in: PubMed
  105. Liang TJ, Hasegawa K, Munoz SJ, Shapiro CN, Yoffe B, McMahon BJ, Feng C, Bei H, Alter MJ, Dienstag JL. Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. J Clin Invest. 1994 Feb; 93(2):550-5.
    View in: PubMed
  106. Katkov WN, Watkins E, DeMelia HC, Dienstag JL. Immunogenicity of a 'pre-S2 plus S' hepatitis B vaccine in healthy adults. J Viral Hepat. 1994; 1(1):79-83.
    View in: PubMed
  107. Davis GL, Lindsay K, Albrecht J, Bodenheimer HC, Balart LA, Perrillo RP, Dienstag JL, Tamburro C, Schiff ER, Carey W, et al. Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group. J Viral Hepat. 1994; 1(1):55-63.
    View in: PubMed
  108. Snydman DR, Werner BG, Dougherty NN, Griffith J, Rubin RH, Dienstag JL, Rohrer RH, Freeman R, Jenkins R, Lewis WD, Hammer S, O'Rourke E, Grady GF, Fawaz K, Kaplan MM, Hoffman MA, Katz AT, Doran M. Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1993 Nov 15; 119(10):984-91.
    View in: PubMed
  109. Bachwich D, Dienstag J. Aplastic anemia and hepatitis C: molecular biology exonerates another suspect. Hepatology. 1993 Feb; 17(2):340-2.
    View in: PubMed
  110. Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC, Balart LA, Ortego TJ, Payne J, Dienstag JL, et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology. 1993 Feb; 104(2):595-603.
    View in: PubMed
  111. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 1992 Nov 15; 149(10):3339-44.
    View in: PubMed
  112. Gibas A, Blewett DR, Schoenfeld DA, Dienstag JL. Prevalence and incidence of viral hepatitis in health workers in the prehepatitis B vaccination era. Am J Epidemiol. 1992 Sep 1; 136(5):603-10.
    View in: PubMed
  113. Leahy D, Kink J, Byrne R, Shah D, Preisel-Simmons B, Laska S, Dienstag J, Thomas H, Karayiannis P, Brown J, et al. Improved serologic detection of hepatitis C virus with a paramagnetic microparticle assay using multiple antigenic sequences. Transfusion. 1992 Jul-Aug; 32(6):548-53.
    View in: PubMed
  114. Delmonico FL, Jenkins RL, Freeman R, Vacanti J, Bradley J, Dienstag JL, Trey C, Lewis WD, Lillehei CW, Auchincloss H, et al. The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg. 1992 May; 127(5):579-84.
    View in: PubMed
  115. Katkov WN, Friedman LS, Cody H, Evans A, Kuo G, Choo QL, Houghton M, Dienstag JL. Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus. Ann Intern Med. 1991 Dec 1; 115(11):882-4.
    View in: PubMed
  116. Katkov WN, Dienstag JL, Cody H, Evans AA, Choo QL, Houghton M, Kuo G. Role of hepatitis C virus in non-B chronic liver disease. Arch Intern Med. 1991 Aug; 151(8):1548-52.
    View in: PubMed
  117. Katkov WN, Dienstag JL. Prevention and therapy of viral hepatitis. Semin Liver Dis. 1991 May; 11(2):165-74.
    View in: PubMed
  118. Dienstag JL. Hepatitis non-A, non-B: C at last. Gastroenterology. 1990 Oct; 99(4):1177-80.
    View in: PubMed
  119. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM, et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med. 1990 Aug 2; 323(5):295-301.
    View in: PubMed
  120. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood. 1990 Jul 1; 76(1):254-6.
    View in: PubMed
  121. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, et al. Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy Group. J Hepatol. 1990; 11 Suppl 1:S31-5.
    View in: PubMed
  122. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med. 1989 Nov 30; 321(22):1501-6.
    View in: PubMed
  123. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, Dienstag JL, Awdeh Z, Yunis EJ. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med. 1989 Sep 14; 321(11):708-12.
    View in: PubMed
  124. Dienstag JL. Passive-active immunoprophylaxis after percutaneous exposure to hepatitis B virus. Hepatology. 1989 Sep; 10(3):385-7.
    View in: PubMed
  125. Chang LJ, Dienstag J, Ganem D, Varmus H. Detection of antibodies against hepatitis B virus polymerase antigen in hepatitis B virus-infected patients. Hepatology. 1989 Sep; 10(3):332-5.
    View in: PubMed
  126. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21; 244(4902):362-4.
    View in: PubMed
  127. Butterly L, Watkins E, Dienstag JL. Recombinant-yeast-derived hepatitis B vaccine in healthy adults: safety and two-year immunogenicity of early investigative lots of vaccine. J Med Virol. 1989 Feb; 27(2):155-9.
    View in: PubMed
  128. Seeff LB, Dienstag JL. Transfusion-associated non-A, non-B hepatitis. Where do we go from here? Gastroenterology. 1988 Aug; 95(2):530-3.
    View in: PubMed
  129. Gibas A, Dienstag JL, Schafer AI, Delmonico F, Bynum TE, Schooley R, Rubin RH, Cosimi AB. Cure of hemophilia A by orthotopic liver transplantation. Gastroenterology. 1988 Jul; 95(1):192-4.
    View in: PubMed
  130. Dienstag JL. Renal transplantation and hepatitis B. Gastroenterology. 1988 Jan; 94(1):235-8.
    View in: PubMed
  131. Surman OS, Dienstag JL, Cosimi AB, Chauncey S, Russell PS. Liver transplantation: psychiatric considerations. Psychosomatics. 1987 Dec; 28(12):615-8, 621.
    View in: PubMed
  132. Dienstag JL. Concurrent hepatitis B surface antigen and antibody and the clonal selection theory of antibody diversity. Gastroenterology. 1987 Oct; 93(4):899-902.
    View in: PubMed
  133. Friedman LS, Dienstag JL, Watkins E, Hinkle CA, Spiers JA, Rieder SV, Huggins CE. Evaluation of blood donors with elevated serum alanine aminotransferase levels. Ann Intern Med. 1987 Aug; 107(2):137-44.
    View in: PubMed
  134. Surman OS, Dienstag JL, Cosimi AB, Chauncey S, Russell PS. Psychosomatic aspects of liver transplantation. Psychother Psychosom. 1987; 48(1-4):26-31.
    View in: PubMed
  135. Craven DE, Awdeh ZL, Kunches LM, Yunis EJ, Dienstag JL, Werner BG, Polk BF, Syndman DR, Platt R, Crumpacker CS, et al. Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med. 1986 Sep; 105(3):356-60.
    View in: PubMed
  136. Dienstag JL. Low-dose intradermal hepatitis B vaccine. JAMA. 1986 Jul 18; 256(3):351.
    View in: PubMed
  137. Friedman LS, Dienstag JL. Recent developments in viral hepatitis. Dis Mon. 1986 Jun; 32(6):313-85.
    View in: PubMed
  138. Elfassi E, Haseltine WA, Dienstag JL. Detection of hepatitis B virus X product using an open reading frame Escherichia coli expression vector. Proc Natl Acad Sci U S A. 1986 Apr; 83(7):2219-22.
    View in: PubMed
  139. Dienstag JL, Alter HJ. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective. Semin Liver Dis. 1986 Feb; 6(1):67-81.
    View in: PubMed
  140. Zeldis JB, Miller JG, Dienstag JL. Hepatitis in an adult with rubella. Am J Med. 1985 Oct; 79(4):515-6.
    View in: PubMed
  141. Friedman LS, O'Brien TF, Morse LJ, Chang LW, Wacker WE, Ryan DM, Dienstag JL. Revisiting the Holy Cross football team hepatitis outbreak (1969) by serological analysis. JAMA. 1985 Aug 9; 254(6):774-6.
    View in: PubMed
  142. Dienstag JL, Werner BG, McLane MF, Snydman DR, Grady GF, Craven DE, Crumpacker CS, Polk BF, Platt R, Allan J, et al. Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination. JAMA. 1985 Aug 23-30; 254(8):1064-6.
    View in: PubMed
  143. Werner BG, Dienstag JL, Kuter BJ, Polk BF, Snydman DR, Craven DE, Crumpacker CS, Platt R, Grady GF. Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccination. Ann Intern Med. 1985 Aug; 103(2):201-5.
    View in: PubMed
  144. Nishioka NS, Dienstag JL. Delta hepatitis: a new scourge? N Engl J Med. 1985 Jun 6; 312(23):1515-6.
    View in: PubMed
  145. Jacobson IM, Nath BJ, Dienstag JL. Relapsing viral hepatitis type A. J Med Virol. 1985 Jun; 16(2):163-9.
    View in: PubMed
  146. Cerra FB, Cheung NK, Fischer JE, Kaplowitz N, Schiff ER, Dienstag JL, Bower RH, Mabry CD, Leevy CM, Kiernan T. Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr. 1985 May-Jun; 9(3):288-95.
    View in: PubMed
  147. Weitberg AB, Weitzman SA, Watkins E, Hinkle C, O'Rourke S, Dienstag JL. Immunogenicity of hepatitis B vaccine in oncology patients receiving chemotherapy. J Clin Oncol. 1985 May; 3(5):718-22.
    View in: PubMed
  148. Jacobson IM, Jaffers G, Dienstag JL, Tolkoff-Rubin NE, Cosimi AB, Delmonico F, Watkins E, Hinkle C, O'Rourke S, Russell PS. Immunogenicity of hepatitis B vaccine in renal transplant recipients. Transplantation. 1985 Apr; 39(4):393-5.
    View in: PubMed
  149. Ross ME, Jacobson IM, Dienstag JL, Martin JB. Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol. 1985 Apr; 17(4):411-3.
    View in: PubMed
  150. Jacobson IM, Dienstag JL, Werner BG, Brettler DB, Levine PH, Mushahwar IK. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology. 1985 Mar-Apr; 5(2):188-91.
    View in: PubMed
  151. Friedman LS, Dienstag JL, Nelson PW, Russell PS, Cosimi AB. Anaphylactic reaction and cardiopulmonary arrest following intravenous cyclosporine. Am J Med. 1985 Feb; 78(2):343-5.
    View in: PubMed
  152. Jacobson IM, Dienstag JL. Viral hepatitis vaccines. Annu Rev Med. 1985; 36:241-61.
    View in: PubMed
  153. Silverstein MD, Mulley AG, Dienstag JL. Should donor blood be screened for elevated alanine aminotransferase levels? A cost-effectiveness analysis. JAMA. 1984 Nov 23-30; 252(20):2839-45.
    View in: PubMed
  154. Jacobson IM, Dienstag JL, Zachoval R, Hanrahan BA, Watkins E, Rubin RH. Lack of effect of hepatitis B vaccine on T-cell phenotypes. N Engl J Med. 1984 Oct 18; 311(16):1030-2.
    View in: PubMed
  155. Dienstag JL, Werner BG, Polk BF, Snydman DR, Craven DE, Platt R, Crumpacker CS, Ouellet-Hellstrom R, Grady GF. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med. 1984 Jul; 101(1):34-40.
    View in: PubMed
  156. Jacobson IM, Dienstag JL. The delta hepatitis agent: "viral hepatitis, type D". Gastroenterology. 1984 Jun; 86(6):1614-7.
    View in: PubMed
  157. Lesser PB, Clement D, Dienstag JL, Bhan AK. Chronic liver disease in Afghanistan: contribution of hepatitis viruses. J Indian Med Assoc. 1983 Nov; 81(9-10):153-5.
    View in: PubMed
  158. Dienstag JL. non-A, Non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention. Gastroenterology. 1983 Sep; 85(3):743-68.
    View in: PubMed
  159. Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology. 1983 Aug; 85(2):439-62.
    View in: PubMed
  160. Dienstag JL, Silverstein MD, Mulley AG. The cost-effectiveness of hepatitis B vaccine. J Infect. 1983 Jul; 7 Suppl 1:81-4.
    View in: PubMed
  161. Ross DS, Daniels GH, Dienstag JL, Ridgway EC. Elevated thyroxine levels due to increased thyroxine-binding globulin in acute hepatitis. Am J Med. 1983 Apr; 74(4):564-9.
    View in: PubMed
  162. Zeldis JB, Dienstag JL, Gale RP. Aplastic anemia and non-A, non-B hepatitis. Am J Med. 1983 Jan; 74(1):64-8.
    View in: PubMed
  163. Collins AB, Bhan AK, Dienstag JL, Colvin RB, Haupert GT, Mushahwar IK, McCluskey RT. Hepatitis B immune complex glomerulonephritis: simultaneous glomerular deposition of hepatitis B surface and e antigens. Clin Immunol Immunopathol. 1983 Jan; 26(1):137-53.
    View in: PubMed
  164. Dienstag JL, Savarese AM, Cohen RB, Bhan AK. Circulating immune complexes in primary biliary cirrhosis: interactions with lymphoid cells. Clin Exp Immunol. 1982 Oct; 50(1):7-16.
    View in: PubMed
  165. Mulley AG, Silverstein MD, Dienstag JL. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med. 1982 Sep 9; 307(11):644-52.
    View in: PubMed
  166. Freund H, Dienstag J, Lehrich J, Yoshimura N, Bradford RR, Rosen H, Atamian S, Slemmer E, Holroyde J, Fischer JE. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy. Ann Surg. 1982 Aug; 196(2):209-20.
    View in: PubMed
  167. Koff RS, Pannuti CS, Pereira ML, Hansson BG, Dienstag JL, Neto VA, Wong DC, Purcell RH. Hepatitis A and non-A, non-B viral hepatitis in São Paulo, Brazil: epidemiological, clinical and laboratory comparisons in hospitalized patients. Hepatology. 1982 Jul-Aug; 2(4):445-8.
    View in: PubMed
  168. Dienstag JL, Stevens CE, Bhan AK, Szmuness W. Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen. Ann Intern Med. 1982 May; 96(5):575-9.
    View in: PubMed
  169. Bhan AK, Dienstag JL, Wands JR, Schlossman SF, Reinherz EL. Alterations of T-cell subsets in primary biliary cirrhosis. Clin Exp Immunol. 1982 Feb; 47(2):351-8.
    View in: PubMed
  170. Dienstag JL, Ryan DM. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol. 1982 Jan; 115(1):26-39.
    View in: PubMed
  171. LaQuaglia MP, Tolkoff-Rubin NE, Dienstag JL, Cosimi AB, Herrin JT, Kelly M, Rubin RH. Impact of hepatitis on renal transplantation. Transplantation. 1981 Dec; 32(6):504-7.
    View in: PubMed
  172. Mushahwar IK, Dienstag JL, Polesky HF, McGrath LC, Decker RH, Overby LR. Interpretation of various serological profiles of hepatitis B virus infection. Am J Clin Pathol. 1981 Dec; 76(6):773-7.
    View in: PubMed
  173. Dienstag JL. Hepatitis A virus: virologic, clinical, and epidemiologic studies. Hum Pathol. 1981 Dec; 12(12):1097-1106.
    View in: PubMed
  174. Dienstag JL, Isselbacher KJ. Therapy for acute and chronic hepatitis. Arch Intern Med. 1981 Oct; 141(11):1419-23.
    View in: PubMed
  175. Dienstag JL, Weake JR, Wands JR. Abnormalities of mononuclear cell regulation in vitro in primary biliary cirrhosis. Liver. 1981 Sep; 1(3):230-43.
    View in: PubMed
  176. Wands JR, Dienstag JL, Weake JR, Koff RS. In vitro studies of enhanced IgG synthesis in severe alcoholic liver disease. Clin Exp Immunol. 1981 May; 44(2):396-404.
    View in: PubMed
  177. Dienstag JL. Immunopathogenesis of the extrahepatic manifestations of hepatitis B virus infection. Springer Semin Immunopathol. 1981 Apr; 3(4):461-72.
    View in: PubMed
  178. Popp JW, Harrist TJ, Dienstag JL, Bhan AK, Wands JR, LaMont JT, Mihm MC. Cutaneous vasculitis associated with acute and chronic hepatitis. Arch Intern Med. 1981 Apr; 141(5):623-9.
    View in: PubMed
  179. Snydman DR, Dienstag JL, Stedt B, Brink EW, Ryan DM, Fawaz KA. Use of IgM-hepatitis A antibody testing. Investigating a common-source, food borne outbreak. JAMA. 1981 Feb 27; 245(8):827-30.
    View in: PubMed
  180. Dienstag JL, Krotoski WA, Howard WA, Purcell RH, Neva FA, Galambos JT, Glew RH. Non-A, non-B hepatitis after experimental transmission of malaria by inoculation of blood. J Infect Dis. 1981 Feb; 143(2):200-9.
    View in: PubMed
  181. Dienstag JL. Hepatitis B as an immune complex disease. Semin Liver Dis. 1981 Feb; 1(1):45-57.
    View in: PubMed
  182. Hansson BG, Calhoun JK, Wong DC, Feinstone SM, Purcell RH, Pannuti CS, Pereira JL, Koff RS, Dienstag JL, Iwarson S. Serodiagnosis of viral hepatitis A by a solid-phase radioimmunoassay specific for IgM antibodies. Scand J Infect Dis. 1981; 13(1):5-9.
    View in: PubMed
  183. Dienstag JL, Bhan AK. Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes. J Immunol. 1980 Nov; 125(5):2269-76.
    View in: PubMed
  184. Dienstag JL. Toward the control of hepatitis B. N Engl J Med. 1980 Oct 9; 303(15):874-6.
    View in: PubMed
  185. Dienstag JL. Halothans hepatitis: allergy or idiosyncrasy? N Engl J Med. 1980 Jul 10; 303(2):102-4.
    View in: PubMed
  186. Popp JW, Dienstag JL, Wands JR, Bloch KJ. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med. 1980 Mar; 92(3):379-83.
    View in: PubMed
  187. Mathieu A, Dienstag JL. [Viral hepatitis. Occupational hazard for anaesthesists (author's transl)]. Anesth Analg (Paris). 1980; 37(7-8):403-7.
    View in: PubMed
  188. Popper H, Dienstag JL, Feinstone SM, Alter HJ, Purcell RH. The pathology of viral hepatitis in chimpanzees. Virchows Arch A Pathol Anat Histol. 1980; 387(1):91-106.
    View in: PubMed
  189. Dienstag JL. Viral hepatitis type A: virology and course. Clin Gastroenterol. 1980 Jan; 9(1):135-54.
    View in: PubMed
  190. Dienstag JL. Non-A, non-B hepatitis. Adv Intern Med. 1980; 26:187-233.
    View in: PubMed
  191. Dienstag JL. Hepatitis viruses: characterization and diagnostic techniques. Yale J Biol Med. 1980 Jan-Feb; 53(1):61-9.
    View in: PubMed
  192. Routenberg JA, Dienstag JL, Harrison WO, Kilpatrick ME, Hooper RR, Chisari FV, Purcell RH, Fornes MF. Foodborne outbreak of hepatitis A: clinical and laboratory features of acute and protracted illness. Am J Med Sci. 1979 Sep-Oct; 278(2):123-37.
    View in: PubMed
  193. Dienstag JL, Bhan AK, Alter HJ, Feinstone SM, Purcell RH. Circulating immune complexes in non-A, non-B hepatitis. Possible masking of viral antigen. Lancet. 1979 Jun 16; 1(8129):1265-7.
    View in: PubMed
  194. Galbraith RM, Dienstag JL, Purcell RH, Gower PH, Zuckerman AJ, Williams R. Non-A non-B hepatitis associated with chronic liver disease in a haemodialysis unit. Lancet. 1979 May 5; 1(8123):951-3.
    View in: PubMed
  195. Mathieu A, Dienstag JL. [Diagnosis of post-operative jaundice (author's transl)]. Anesth Analg (Paris). 1979 May-Jun; 36(5-6):181-4.
    View in: PubMed
  196. Dienstag JL. The pathobiology of hepatitis A virus. Int Rev Exp Pathol. 1979; 20:1-48.
    View in: PubMed
  197. Dienstag JL. Hepatitis A virus: identification, characterization, and epidemiologic investigations. Prog Liver Dis. 1979; 6:343-70.
    View in: PubMed
  198. Dienstag JL. Hepatitis B virus infection: more than meets the eye. Gastroenterology. 1978 Dec; 75(6):1172-4.
    View in: PubMed
  199. Wands JR, Dienstag JL. Inhibition of lymphocyte cytotoxicity by serum from patients with alcoholic liver disease: partial characterization of serum inhibitors. Yale J Biol Med. 1978 Nov-Dec; 51(6):615-23.
    View in: PubMed
  200. Dienstag JL, Isselbacher KJ. Plasma alpha-amino-n-butyric acid to leucine ratio in perspective. Gastroenterology. 1978 Nov; 75(5):928.
    View in: PubMed
  201. Dienstag JL, Carter EA, Wands JR, Isselbacher KJ, Fischer JE. Plasma alpha-amino-n-butyric acid to leucine ratio: nonspecificity as a marker for alcoholism. Gastroenterology. 1978 Oct; 75(4):561-5.
    View in: PubMed
  202. Dienstag JL, Isselbacher KJ. Liver-specific protein: more questions than answers. N Engl J Med. 1978 Jul 6; 299(1):40-2.
    View in: PubMed
  203. Dienstag JL, Rhodes AR, Bhan AK, Dvorak AM, Mihm MC, Wands JR. Urticaria associated with acute viral hepatitis type B: studies of pathogenesis. Ann Intern Med. 1978 Jul; 89(1):34-40.
    View in: PubMed
  204. Stevens CE, Silbert JA, Miller DR, Dienstag JL, Purcell RH, Szmuness W. Serologic evidence of hepatitis A and B virus infections in thalassemia patients: a retrospective study. Transfusion. 1978 May-Jun; 18(3):356-60.
    View in: PubMed
  205. Cherubin CE, Nair SR, Dienstag JL, Purcell RH, Szmuness W. Antibody to hepatitis A and B in children in New York City. Pediatrics. 1978 May; 61(5):781-3.
    View in: PubMed
  206. Dienstag JL, Szmuness W, Stevens CE, Purcell RH. Hepatitis A virus infection: new insights from seroepidemiologic studies. J Infect Dis. 1978 Mar; 137(3):328-40.
    View in: PubMed
  207. Wands JR, Dienstag JL, Bhan AK, Feller ER, Isselbacher KJ. Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med. 1978 Feb 2; 298(5):233-7.
    View in: PubMed
  208. Alpert E, Dienstag JL, Sepersky S, Littman B, Rocklin R. Immunosuppressive characteristics of human AFP: effect on tests of cell mediated immunity and induction of human suppressor cells. Immunol Commun. 1978; 7(2):163-85.
    View in: PubMed
  209. Szmuness W, Dienstag JL, Purcell RH, Stevens CE, Wong DC, Ikram H, Bar-Shany S, Beasley RP, Desmyter J, Gaon JA. The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol. 1977 Nov; 106(5):392-8.
    View in: PubMed
  210. Barker LF, Dienstag JL, Lorenz DE, Purcell RH, Wong DC, Feinstone SM, Peterson MR, Rosen MW. Serologic and animal inoculation studies of a communal outbreak of viral hepatitis, type A. Am J Med Sci. 1977 Nov-Dec; 274(3):247-53.
    View in: PubMed
  211. Dienstag JL, Wands JR, Isselbacher KJ. Hepatitis B and essential mixed cryoglobulinemia. N Engl J Med. 1977 Oct 27; 297(17):946-7.
    View in: PubMed
  212. Stevens CE, Cherubin CE, Dienstag JL, Purcell RH, Szmuness W. Antibody to hepatitis A antigen in children. J Pediatr. 1977 Sep; 91(3):436-8.
    View in: PubMed
  213. Dienstag JL, Alaama A, Mosley JW, Redeker AG, Purcell RH. Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med. 1977 Jul; 87(1):1-6.
    View in: PubMed
  214. Szmuness W, Dienstag JL, Purcell RH, Prince AM, Stevens CE, Levine RW. Hepatitis type A and hemodialysis: a seroepidemiologic study in 15 U.S. centers. Ann Intern Med. 1977 Jul; 87(1):8-12.
    View in: PubMed
  215. Dienstag JL, Purcell RH. Hepatitis A antigen: clinical implications. Compr Ther. 1977 Jul; 3(7):34-41.
    View in: PubMed
  216. Dienstag JL, Purcell RH. Recent advances in the identification of hepatitis viruses. Postgrad Med J. 1977 Jul; 53(621):364-73.
    View in: PubMed
  217. Meyers JD, Dienstag JL, Purcell RH, Thomas ED, Holmes KK. Parenterally transmitted non-A, non-B hepatitis: an epidemic reassessed. Ann Intern Med. 1977 Jul; 87(1):57-9.
    View in: PubMed
  218. Szmuness W, Purcell RH, Dienstag JL, Stevens CE. Antibody to hepatitis A antigen in institutionalized mentally retarded patients. JAMA. 1977 Apr 18; 237(16):1702-5.
    View in: PubMed
  219. Dienstag JL, Purcell HR, Alter HJ, Feinstone SM, Wong DC, Holland PV. Non-A, non-B post-transfusion hepatitis. Lancet. 1977 Mar 12; 1(8011):560-2.
    View in: PubMed
  220. Schaffner F, Dienstag JL, Purcell RH, Popper H. Chimpanzee livers after infection with human hepatitis viruses A and B: Ultrastructural studies. Arch Pathol Lab Med. 1977 Mar; 101(3):113-7.
    View in: PubMed
  221. Jablecki C, Dienstag J, Kaufman S. [3H]inositol incorporation into phosphatidyl-inositol in work-induced growth of rat muscle. Am J Physiol. 1977 Mar; 232(3):E324-9.
    View in: PubMed
  222. Hooper RR, Juels CW, Routenberg JA, Harrison WO, Kilpatrick ME, Kendra SJ, Dienstag JL. An outbreak of type A viral hepatitis at the Naval Training Center, San Diego: epidemiologic evaluation. Am J Epidemiol. 1977 Feb; 105(2):148-55.
    View in: PubMed
  223. Gust ID, Dienstag JL, Purcell RH, Lucas CR. Non-B hepatitis in Melbourne: a serological study of hepatitis A virus infection. Br Med J. 1977 Jan 22; 1(6055):193-5.
    View in: PubMed
  224. Dienstag JL, Cline WL, Purcell RH. Detection of cytomegalovirus antibody by immune adherence hemagglutination. Proc Soc Exp Biol Med. 1976 Dec; 153(3):543-8.
    View in: PubMed
  225. Dienstag JL, Wagner JA, Purcell RH, London WT, Lorenz DE. Virus-like particles and GB agent hepatitis. Nature. 1976 Nov 18; 264(5583):260-1.
    View in: PubMed
  226. Tiku ML, Beutner KR, Ramirez RI, Dienstag JL, Sultz HA, Ogra PL. Distribution and characteristics of hepatitis B surface antigen in body fluids of institutionalized children and adults. J Infect Dis. 1976 Oct; 134(4):342-7.
    View in: PubMed
  227. Dienstag JL, Popper H, Purcell RH. The pathology of viral hepatitis types A and B in chimpanzees. A comparison. Am J Pathol. 1976 Oct; 85(1):131-48.
    View in: PubMed
  228. Dienstag JL, Krugman S, Wong DC, Purcell RH. Comparison of serological tests for antibody to hepatitis A antigen, using coded specimens from individuals infected with the MS-1 strain of hepatitis A virus. Infect Immun. 1976 Oct; 14(4):1000-3.
    View in: PubMed
  229. Szmuness W, Dienstag JL, Purcell RH, Harley EJ, Stevens CE, Wong DC. Distribution of antibody to hepatitis a antigen in urban adult populations. N Engl J Med. 1976 Sep 30; 295(14):755-9.
    View in: PubMed
  230. Dienstag JL, Schulman AN, Gerety RJ, Hoofnagle JH, Lorenz DE, Purcell RH, Barker LF. Hepatitis A antigen isolated from liver and stool: immunologic comparison of antisera prepared in guinea pigs. J Immunol. 1976 Sep; 117(3):876-81.
    View in: PubMed
  231. Farivar M, Wands JR, Benson GD, Dienstag JL, Isselbacher KJ. Cryoprotein complexes and peripheral neuropathy in a patient with chronic active hepatitis. Gastroenterology. 1976 Sep; 71(3):490-3.
    View in: PubMed
  232. Dienstag JL, Davenport FM, McCollum RW, Hennessy AV, Klatskin G, Purcell RH. Nonhuman primate-associated viral hepatitis type A. Serologic evidence of hepatitis A virus infection. JAMA. 1976 Aug 2; 236(5):462-4.
    View in: PubMed
  233. Purcell RH, Alter HJ, Dienstag JL. Non-A, non-B hepatitis. Yale J Biol Med. 1976 Jul; 49(3):243-50.
    View in: PubMed
  234. Schulman AN, Dienstag JL, Jackson DR, Hoofnagle JH, Gerety RJ, Purcell RH, Barker LF. Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. J Infect Dis. 1976 Jul; 134(1):80-4.
    View in: PubMed
  235. Dienstag JL, Alling DW, Purcell RH. Quantitation of antibody to hepatitis A antigen by immune electron microscopy. Infect Immun. 1976 Apr; 13(4):1209-13.
    View in: PubMed
  236. Dienstag JL, Gust ID, Lucas CR, Wong DC, Purcell RH. Mussel-associated viral hepatitis, type A: serological confirmation. Lancet. 1976 Mar 13; 1(7959):561-3.
    View in: PubMed
  237. Moritsugu Y, Dienstag JL, Valdesuso J, Wong DC, Wagner J, Routenberg JA, Purcell RH. Purification of hepatitis A antigen from feces and detection of antigen and antibody by immune adherence hemagglutination. Infect Immun. 1976 Mar; 13(3):898-908.
    View in: PubMed
  238. Purcell RH, Wong DC, Moritsugu Y, Dienstag JL, Routenberg JA, Boggs JD. A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody. J Immunol. 1976 Feb; 116(2):349-56.
    View in: PubMed
  239. Knodell RG, Conrad ME, Dienstag JL, Bell CJ. Etiological spectrum of post-transfusion hepatitis. Gastroenterology. 1975 Dec; 69(6):1278-85.
    View in: PubMed
  240. Dienstag JL, Routenberg JA, Purcell RH, Hooper RR, Harrison WO. Foodhandler-associated outbreak of hepatitis type A. An immune electron microscopic study. Ann Intern Med. 1975 Nov; 83(5):647-50.
    View in: PubMed
  241. Dienstag JL, Feinstone SM, Purcell RH, Hoofnagle JH, Barker LF, London WT, Popper H, Peterson JM, Kapikian AZ. Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis. 1975 Nov; 132(5):532-45.
    View in: PubMed
  242. Purcell RH, Dienstag JL, Feinstone SM, Kapikian AZ. Relationship of hepatitis A antigen to viral hepatitis. Am J Med Sci. 1975 Jul-Aug; 270(1):61-71.
    View in: PubMed
  243. Dienstag JL, Feinstone SM, Kapikian AZ, Purcell RH. Faecal shedding of hepatitis-A antigen. Lancet. 1975 Apr 5; 1(7910):765-7.
    View in: PubMed
  244. Dienstag JL, Feinstone SM, Kapikian AZ, Purcell RH. Letter: Immune electron microscopy and hepatitis A. Lancet. 1975 Jan 11; 1(7898):102.
    View in: PubMed
  245. Dienstag JL, Pelon W, Tyeryar F, Purcell RH. Serologic comparison of hepatitis A antigen to echovirus 25 isolate CR69(076) recovered from a patient with viral hepatitis. Intervirology. 1975-1976; 6(4-5):319-24.
    View in: PubMed
  246. Dienstag J, Neu HC. In vitro studies of tobramycin, an aminoglycoside antibiotic. Antimicrob Agents Chemother. 1972 Jan; 1(1):41-5.
    View in: PubMed
  247. Morreal CE, Dao TL, Eskins K, King CL, Dienstag J. Peroxide induced binding of hydrocarbons to DNA. Biochim Biophys Acta. 1968 Nov 20; 169(1):224-9.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Dienstag's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_